Novavax (NVAX) Net Equity Issued and Repurchased (2010 - 2024)
Novavax (NVAX) recorded Net Equity Issued and Repurchased of $263.27 million in FY2024, down 26.9% from $360.24 million in FY2023.
Powered by 
Analysis
Novavax (NVAX) Net Equity Issued and Repurchased (2010 - 2024) Analysis & Trends
Starting with FY2009, Novavax's Net Equity Issued and Repurchased history includes 16 years.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 22.0% (FY2019 to FY2024).
- Annual Net Equity Issued and Repurchased has ranged from $249.23 million in FY2022 to $875.62 million in FY2020 over the past five years.
- Per Business Quant data, NVAX's Net Equity Issued and Repurchased was $360.24 million in FY2023 (+44.5%), $249.23 million in FY2022 (-55.9%), $564.86 million in FY2021 (-35.5%) and $875.62 million in FY2020 (+799.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Novavax | 1.78 Bn | -1.23 Bn | 42.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 256.41 Mn |
| Mar 31, 2024 | 6.86 Mn |
| Dec 31, 2023 | 103.25 Mn |
| Sep 30, 2023 | 195.01 Mn |
| Jun 30, 2023 | 61.99 Mn |
| Dec 31, 2022 | 69.85 Mn |
| Mar 31, 2022 | 179.39 Mn |
| Mar 31, 2021 | 564.86 Mn |
| Dec 31, 2020 | 428.55 Mn |
| Mar 31, 2020 | 185.92 Mn |
| Dec 31, 2019 | 30.17 Mn |
| Sep 30, 2019 | 11.98 Mn |
| Jun 30, 2019 | 3,000.00 |
| Mar 31, 2019 | 55.24 Mn |
| Dec 31, 2018 | 3.57 Mn |
| Jun 30, 2018 | 53.89 Mn |
| Mar 31, 2018 | 42.60 Mn |
| Dec 31, 2017 | 17.40 Mn |
| Sep 30, 2017 | 23.29 Mn |
| Jun 30, 2017 | 8.15 Mn |
API Access
Novavax Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();